RT Journal Article
SR Electronic
T1 Demographic and Clinical Characteristics of the Severe Covid-19 Infections: First Report from Mashhad University of Medical Sciences, Iran
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.20.20108068
DO 10.1101/2020.05.20.20108068
A1 Ladan Goshayeshi
A1 Mina Akbari Rad
A1 Robert Bergquist
A1 Abolghasem Allahyari
A1 members of the MUMS Covid-19 Research Team
A1 Benyamin Hoseini
YR 2020
UL http://medrxiv.org/content/early/2020/09/23/2020.05.20.20108068.abstract
AB Background Coronavirus Disease 2019 (Covid-19) is expanding worldwide. The characteristics of this infection in patients varies from country to country. To move forward, clinical data on infected patients are needed. Here, we report a comparison between fatalities and recovery of patients with severe Covid-19, based on demographic and clinical characteristics.Methods Between 5 March and 12 May 2020 in Mashhad, Iran, 1,278 of 4,000 suspected Covid-19 patients were confirmed positive by real-time reverse-transcriptase–polymerase-chain-reaction assay of upper respiratory specimens. We compared the demographic, exposure history and clinical symptoms of 925 survivors and 353 fatal cases with confirmed disease.Results Mean (SD) age for all confirmed patients was 56.9 (18.7) years, 67.1 (15.9) years in fatal cases and 53.0 (18.3) years in survivors. Multivariable logistic regression analysis showed that the outcome of patients was associated with age (OR = 1.049, P = 0.0001, 95% CI = 1.040-1.057). Despite a high burden of Covid-19 infections in the 30-39 and 40-49 year age groups, most of these (89.6% and 87.2%, respectively) recovered. The median (IQR) duration of hospitalization was 9.0 (6.0-14.0) days. The most prevalent co-morbidities were cardiovascular disorders (21%) and diabetes (16.3%). Dyspnoea (72.7%), cough (68.1%) and fever (63.8%) were the most frequent clinical symptoms. Healthcare workers, of whom two (3%) died, comprised 5.2% of infected-cases. Combination antiviral and antibiotic therapy was used in 43.0% of cases.Conclusions The characteristics of severe Covid-19 varied substantially between fatal cases and survivors, with diabetes and cardiovascular disorders the most prevalent co-morbidities. In contrast to other studies, there were a higher number of fatalities in younger patients in our settings.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialthis is not a trial study. this is a retrospective study.Funding StatementThis work was supported by Mashhad University of Medical Sciences (grant number of 981800).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics code: IR.MUMS.REC.1398.308All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be available upon request by permission of the corresponding author and Research Ethics Committee of Mashhad University of Medical Sciences.Covid-19Coronavirus Disease 2019SARS-CoV-2severe acute respiratory syndrome coronavirus 2SARSsevere acute respiratory syndromeICUintensive care unitRT-PCRreal-time reverse-transcriptase polymerase chain reaction